Skip to content
Screener

Nutex Health Inc. NUTX Q4 2025 Annual earnings

Reported March 5, 2026 · After market close

Revenue$151.7MMiss by $107.1M
EPS$1.61Miss by $3.95
Revenue estimate$258.8M
EPS estimate$5.56

Next report

Nov 17, 2026 (in 2 months)
Revenue estimate$215.0M
EPS estimate$5.71

Financials

Q4 2025

Income statement

See full
Revenue$151.7M-41.1%
Gross profit$46.1M-67.4%
Operating income$30.9M-72.9%
Net income$11.8M-80.8%
EPS (diluted)$1.61-85.5%

Balance sheet

See full
Cash & equivalents$185.9M+357%
Total debt$350.7M+4.1%
Total equity$329.4M+149%
Total assets$918.5M+40.2%

Cash flow

See full
Operating cash flow$70.4M+130,250%
CapEx$1.4M+257%
Free cash flow$69.0M—

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$1.16B+576%
Enterprise value$1.33B+184%
P/E16.4×+13.1×
P/S1.3×+1.0×

Profitability

See full
Gross margin50.8%+9.9pp
Operating margin31.5%+4.3pp
Net margin8.1%-2.8pp
FCF margin28.1%+23.6pp

Returns & leverage

See full
Return on equity30.7%-23.2pp
Debt / equity1.1×-1.5×
Current ratio3.4×+1.5×

FAQ

When did Nutex Health Inc. report Q4 2025 earnings?
Nutex Health Inc. (NUTX) reported Q4 2025 earnings on March 5, 2026 after market close.
What were Nutex Health Inc.'s Q4 2025 revenue and EPS?
Nutex Health Inc. reported revenue of $151.7M and eps of $1.61 for Q4 2025.
Did Nutex Health Inc. beat estimates in Q4 2025?
Revenue missed the consensus estimate of $258.8M by $107.1M. EPS missed the consensus estimate of $5.56 by $3.95.
How did Nutex Health Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 41.1% from $257.6M a year earlier and eps declined 85.5% from $11.12.
Where can I find Nutex Health Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001628280-26-015174) and the 10-K periodic report (0001628280-26-015168) directly on SEC EDGAR. The filing index links above go to sec.gov.